Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Lexeo Therapeutics, Inc. (LXEO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Lexeo Therapeutics, Inc. (LXEO), most recent 12 months reported: net loss $87.27M, free cash flow -$88.7M. Latest balance sheet on file: liquid cash $211.7M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Kodiak Sciences Inc. · Kyverna Therapeutics, Inc. · LIMINATUS PHARMA, INC. · LeonaBio, Inc. · MAZE THERAPEUTICS, INC. · NEUMORA THERAPEUTICS, INC. · OUTLOOK THERAPEUTICS, INC. · PALISADE BIO, INC.

Stock screener

Watchlist